In vitro activity of Bay 12-8039, a new 8-methoxyquinolone

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 8, 1997, Pages 1818-1824

  Fass, Robert J ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 CYCLOPROPYL 7 (2,8 DIAZABICYCLO[4,3,0]NON 8 YL) 6 FLUORO 8 METHOXY 1,4 DIHYDRO 4 OXO 3 QUINOLINE; AMOXICILLIN PLUS CLAVULANIC ACID; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; LORACARBEF; MOXIFLOXACIN; OFLOXACIN; QUINOLONE DERIVATIVE; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANAEROBIC BACTERIUM; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; ENTEROBACTERIACEAE; ENTEROCOCCUS; HAEMOPHILUS INFLUENZAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STREPTOCOCCUS;

EID: 0030762476     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.8.1818     Document Type: Article

References (11)

1. Barry, A. L., and P. C. Fuchs. 1991. Cross-resistance and cross-susceptibility between fluoroquinolone agents. Eur. J. Clin. Microbiol. Infect. Dis. 10:1013-1018.
2. Fass, R. J. 1983. In vitro activity of ciprofloxacin (Bay o 9867). Antimicrob. Agents Chemother. 24:568-574.
3. Fass, R. J. 1993. In vitro activity of Bay y 3118, a new quinolone. Antimicrob. Agents Chemother. 37:2348-2357.
4. Fass, R. J. 1994. Use of frequency distribution curves, scattergrams and regression analyses to compare in vitro activities and describe cross-susceptibility and cross-resistance among four quinolones. J. Chemother. 6:368-376.
5. Fass, R. J., J. Barnishan, M. C. Solomon, and L. W. Ayers. 1996. In vitro activities of quinolones, β-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob. Agents Chemother. 40:1412-1418.
6. King, A., L. Bethune, and I. Phillips. 1991. The in-vitro activity of tosufloxacin, a new fluorinated quinolone, compared with that of ciprofloxacin and temafloxacin. J. Antimicrob. Chemother. 28:719-725.
7. National Committee for Clinical Laboratory Standards. 1993. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 3rd ed. Approved standard M7-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
8. National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria, 3rd ed. Approved standard M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa.
9. National Committee for Clinical Laboratory Standards. 1995. Performance standards for antimicrobial susceptibility testing. Sixth informational supplement M100-S6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10. Thomson, K. S., C. C. Sanders, and M. E. Hayden. 1991. In vitro studies with five quinolones: evidence for changes in relative potency as quinolone resistance rises. Antimicrob. Agents Chemother. 35:2329-2334.
11. Woodcock, J. M., J. M. Andrews, F. J. Boswell, N. P. Brenwald, and R. Wise. 1997. The in vitro activity of Bay 12-8039, a new fluoroquinolone. Antimicrob. Agents Chemother. 41:101-106.